ARS Investment Partners LLC Purchases 11,575 Shares of BWX Technologies, Inc. $BWXT

ARS Investment Partners LLC boosted its holdings in shares of BWX Technologies, Inc. (NYSE:BWXT) by 48.4% in the 1st quarter, HoldingsChannel.com reports. The institutional investor owned 35,489 shares of the technology company’s stock after buying an additional 11,575 shares during the quarter. ARS Investment Partners LLC’s holdings in BWX Technologies were worth $7,257,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds and other institutional investors have also added to or reduced their stakes in BWXT. Diversified Trust Co purchased a new stake in shares of BWX Technologies in the 1st quarter worth $207,000. Thompson Davis & CO. Inc. purchased a new position in BWX Technologies during the first quarter valued at $235,000. Hsbc Holdings PLC lifted its position in BWX Technologies by 260.2% during the fourth quarter. Hsbc Holdings PLC now owns 7,770 shares of the technology company’s stock valued at $1,348,000 after purchasing an additional 5,613 shares in the last quarter. Rockefeller Capital Management L.P. grew its holdings in BWX Technologies by 3.4% during the fourth quarter. Rockefeller Capital Management L.P. now owns 28,172 shares of the technology company’s stock valued at $4,869,000 after purchasing an additional 926 shares during the period. Finally, ARP Global Capital Ltd bought a new stake in BWX Technologies during the fourth quarter valued at about $3,538,000. 94.39% of the stock is owned by hedge funds and other institutional investors.

BWX Technologies Trading Down 0.1%

Shares of BWX Technologies stock opened at $205.14 on Friday. BWX Technologies, Inc. has a fifty-two week low of $133.84 and a fifty-two week high of $241.82. The company has a debt-to-equity ratio of 1.58, a quick ratio of 2.33 and a current ratio of 2.40. The company has a market capitalization of $18.79 billion, a P/E ratio of 54.85, a P/E/G ratio of 3.38 and a beta of 0.73. The company has a fifty day moving average of $207.75 and a 200 day moving average of $200.87.

BWX Technologies (NYSE:BWXT) last posted its quarterly earnings results on Monday, May 4th. The technology company reported $1.12 EPS for the quarter, beating analysts’ consensus estimates of $0.92 by $0.20. BWX Technologies had a return on equity of 31.33% and a net margin of 10.20%.The business had revenue of $860.22 million for the quarter, compared to analysts’ expectations of $837.47 million. During the same period last year, the firm earned $0.91 earnings per share. The business’s quarterly revenue was up 26.1% on a year-over-year basis. BWX Technologies has set its FY 2026 guidance at 4.600-4.750 EPS. On average, sell-side analysts anticipate that BWX Technologies, Inc. will post 4.71 earnings per share for the current fiscal year.

BWX Technologies Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Friday, June 5th. Investors of record on Tuesday, May 19th were given a dividend of $0.27 per share. The ex-dividend date was Tuesday, May 19th. This represents a $1.08 annualized dividend and a dividend yield of 0.5%. BWX Technologies’s dividend payout ratio (DPR) is currently 28.88%.

Insider Activity at BWX Technologies

In other BWX Technologies news, CFO Michael Thomas Fitzgerald sold 2,417 shares of the company’s stock in a transaction that occurred on Monday, May 11th. The stock was sold at an average price of $209.25, for a total value of $505,757.25. Following the completion of the transaction, the chief financial officer directly owned 6,884 shares in the company, valued at $1,440,477. This represents a 25.99% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Also, CEO Rex D. Geveden sold 10,000 shares of the company’s stock in a transaction that occurred on Tuesday, May 12th. The stock was sold at an average price of $204.81, for a total value of $2,048,100.00. Following the completion of the transaction, the chief executive officer owned 202,491 shares of the company’s stock, valued at $41,472,181.71. The trade was a 4.71% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 0.60% of the stock is currently owned by company insiders.

Analysts Set New Price Targets

Several research firms have recently commented on BWXT. Weiss Ratings reaffirmed a “buy (b-)” rating on shares of BWX Technologies in a research note on Friday, May 22nd. TD Cowen started coverage on BWX Technologies in a research note on Thursday, March 12th. They set a “buy” rating and a $230.00 price objective for the company. Wall Street Zen upgraded BWX Technologies from a “hold” rating to a “buy” rating in a research note on Saturday, May 9th. Wells Fargo & Company started coverage on shares of BWX Technologies in a report on Wednesday, April 1st. They issued an “underweight” rating and a $200.00 target price for the company. Finally, Bank of America raised their target price on shares of BWX Technologies from $230.00 to $250.00 and gave the stock a “buy” rating in a research note on Wednesday, March 25th. Two equities research analysts have rated the stock with a Strong Buy rating, eight have assigned a Buy rating, four have assigned a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus price target of $228.00.

BWX Technologies Company Profile

BWX Technologies, Inc (NYSE: BWXT) is a specialized supplier of nuclear components and services, primarily serving the U.S. government and commercial markets. The company’s core expertise lies in the design, fabrication and servicing of nuclear propulsion systems for the U.S. Navy, where it supports the maintenance and overhaul of naval nuclear reactors. In addition to defense applications, BWXT develops small modular reactors (SMRs), nuclear fuel and related technologies for non‐defense power generation, offering scalable solutions to meet evolving energy and industrial demands.

Beyond propulsion and power systems, BWXT is a leading producer of medical radioisotopes used in diagnostic imaging and cancer treatment.